ANTICORPS ANTI-CXCL13 ET LEURS PROCÉDÉS D'UTILISATION
- 专利权人:
- Vaccinex; Inc.
- 发明人:
- 申请号：
- EP11822655.4
- 公开号：
- EP2611832B1
- 申请日:
- 2011.09.01
- 申请国别(地区):
- EP
- 年份:
- 2017
- 代理人:
- 摘要：
- Compositions and methods are provided for treating diseases associated with CXCL13 expression, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CXCL13 monoclonal antibodies have been developed to neutralize CXCL13.
- 来源网站：
- 中国工程科技知识中心
